ERVK-9 Blocking Peptide (C-Term)
€363.00
In stock
SKU
AC-BP21916b
Background:
Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its original fusogenic properties.
Other Names:
Endogenous retrovirus group K member 9 Env polyprotein, EnvK4 protein, Envelope polyprotein, HERV-K(C6) envelope protein, HERV-K109 envelope protein, HERV-K_6q14.1 provirus ancestral Env polyprotein, Surface protein, SU, Transmembrane protein, TM, ERVK-9
Target/Specificity:
The synthetic peptide sequence is selected from aa 656-669 of HUMAN ERVK-9
Gene Name: ERVK-9
Primary Accession: Q9UKH3
Other Accession: Q902F9;O71037;P61565;P61566;Q69384;P61567;Q902F8;P63135
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its original fusogenic properties.
Other Names:
Endogenous retrovirus group K member 9 Env polyprotein, EnvK4 protein, Envelope polyprotein, HERV-K(C6) envelope protein, HERV-K109 envelope protein, HERV-K_6q14.1 provirus ancestral Env polyprotein, Surface protein, SU, Transmembrane protein, TM, ERVK-9
Target/Specificity:
The synthetic peptide sequence is selected from aa 656-669 of HUMAN ERVK-9
Gene Name: ERVK-9
Primary Accession: Q9UKH3
Other Accession: Q902F9;O71037;P61565;P61566;Q69384;P61567;Q902F8;P63135
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review